Live Breaking News & Updates on Other Mcgovern Medical School

Stay updated with breaking news from Other mcgovern medical school. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

First in the nation, FDA-approved Phase II mesenchymal stem cell therapy for Parkinson's disease begins


(Photo courtesy of Getty Images)
The goal of this Phase II study is to determine the safest and most effective number of doses of stem cells to slow the progression of Parkinson s disease symptoms so patients can continue to enjoy their active lives.
Newswise A Phase II clinical trial to assess mesenchymal adult stem cells as a disease-modifying therapy for Parkinson s disease has been launched at The University of Texas Health Science Center at Houston (UTHealth). 
Studies have shown mesenchymal stem cells can migrate to the sites of injury and respond to the environment by secreting several anti-inflammatory and growth factor molecules that can restore tissue equilibrium and disrupt neuronal death, said Mya C. Schiess, MD, professor in the Department of Neurology and director and founder of the movement disorder subspeciality clinic and fellowship program at McGovern Medical School at UTHealth. The stem cells interact directly with the immune cells, leading t ....

United States , New York , Marie Francoise Doursout , Sean Savitz , Charles Green , Kyle Kirksey , Myac Schiess , Timothym Ellmore , Jessika Suescun , Jeromeg Saltarrelli , Christopher Adams , Movement Disorders , Department Of Psychology , City College Of New York , Department Of Neurology , Drug Administration , Department Of Anesthesiology , Department Of Surgery , Other Mcgovern Medical School , Johns Dunn Foundation , Mcgovern Medical School , Michaelj Fox Foundation , Department Of Pediatrics , Texas Health Science Center , City College , ஒன்றுபட்டது மாநிலங்களில் ,